78 related articles for article (PubMed ID: 9675211)
1. Ultraviolet resonance Raman study of drug binding in dihydrofolate reductase, gyrase, and catechol O-methyltransferase.
Couling VW; Fischer P; Klenerman D; Huber W
Biophys J; 1998 Aug; 75(2):1097-106. PubMed ID: 9675211
[TBL] [Abstract][Full Text] [Related]
2. Quaternary structure sensitive tyrosine residues in human hemoglobin: UV resonance raman studies of mutants at alpha140, beta35, and beta145 tyrosine.
Nagai M; Wajcman H; Lahary A; Nakatsukasa T; Nagatomo S; Kitagawa T
Biochemistry; 1999 Jan; 38(4):1243-51. PubMed ID: 9930984
[TBL] [Abstract][Full Text] [Related]
3. Backbone resonance assignment of the N-terminal 24 kDa fragment of the gyrase B subunit from S. aureus complexed with novobiocin.
Klaus W; Ross A; Gsell B; Senn H
J Biomol NMR; 2000 Apr; 16(4):357-8. PubMed ID: 10826892
[No Abstract] [Full Text] [Related]
4. Crystal structure of catechol O-methyltransferase.
Vidgren J; Svensson LA; Liljas A
Nature; 1994 Mar; 368(6469):354-8. PubMed ID: 8127373
[TBL] [Abstract][Full Text] [Related]
5. The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study.
Holdgate GA; Tunnicliffe A; Ward WH; Weston SA; Rosenbrock G; Barth PT; Taylor IW; Pauptit RA; Timms D
Biochemistry; 1997 Aug; 36(32):9663-73. PubMed ID: 9245398
[TBL] [Abstract][Full Text] [Related]
6. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
Tsai FT; Singh OM; Skarzynski T; Wonacott AJ; Weston S; Tucker A; Pauptit RA; Breeze AL; Poyser JP; O'Brien R; Ladbury JE; Wigley DB
Proteins; 1997 May; 28(1):41-52. PubMed ID: 9144789
[TBL] [Abstract][Full Text] [Related]
7. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.
Oefner C; Bandera M; Haldimann A; Laue H; Schulz H; Mukhija S; Parisi S; Weiss L; Lociuro S; Dale GE
J Antimicrob Chemother; 2009 Apr; 63(4):687-98. PubMed ID: 19211577
[TBL] [Abstract][Full Text] [Related]
8. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR
Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600
[TBL] [Abstract][Full Text] [Related]
9. Directed evolution of trimethoprim resistance in Escherichia coli.
Watson M; Liu JW; Ollis D
FEBS J; 2007 May; 274(10):2661-71. PubMed ID: 17451440
[TBL] [Abstract][Full Text] [Related]
10. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
Cody V; Pace J; Chisum K; Rosowsky A
Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
[TBL] [Abstract][Full Text] [Related]
11. Refolding of [6-19F]tryptophan-labeled Escherichia coli dihydrofolate reductase in the presence of ligand: a stopped-flow NMR spectroscopy study.
Hoeltzli SD; Frieden C
Biochemistry; 1998 Jan; 37(1):387-98. PubMed ID: 9425060
[TBL] [Abstract][Full Text] [Related]
12.
Czarnota S; Baxter NJ; Cliff MJ; Waltho JP; Scrutton NS; Hay S
Biomol NMR Assign; 2017 Apr; 11(1):57-61. PubMed ID: 27981425
[TBL] [Abstract][Full Text] [Related]
13. Measuring propargyl-linked drug populations inside bacterial cells, and their interaction with a dihydrofolate reductase target, by Raman microscopy.
Heidari-Torkabadi H; Che T; Lombardo MN; Wright DL; Anderson AC; Carey PR
Biochemistry; 2015 May; 54(17):2719-26. PubMed ID: 25871808
[TBL] [Abstract][Full Text] [Related]
14. DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex.
Critchlow SE; Maxwell A
Biochemistry; 1996 Jun; 35(23):7387-93. PubMed ID: 8652515
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of rat soluble catechol-O-methyltransferase fusion protein.
Bonifácio MJ; Vieira-Coelho MA; Soares-da-Silva P
Protein Expr Purif; 2001 Oct; 23(1):106-12. PubMed ID: 11570851
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of the apo and holo form of rat catechol-O-methyltransferase.
Tsuji E; Okazaki K; Isaji M; Takeda K
J Struct Biol; 2009 Mar; 165(3):133-9. PubMed ID: 19111934
[TBL] [Abstract][Full Text] [Related]
17. Ultraviolet resonance Raman spectroscopy as a probe of protein structure in the fd virus.
Grygon CA; Perno JR; Fodor SP; Spiro TG
Biotechniques; 1988 Jan; 6(1):50-5. PubMed ID: 3273393
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
[TBL] [Abstract][Full Text] [Related]
20. Temperature-sensitive suppressor mutations of the Escherichia coli DNA gyrase B protein.
Blance SJ; Williams NL; Preston ZA; Bishara J; Smyth MS; Maxwell A
Protein Sci; 2000 May; 9(5):1035-7. PubMed ID: 10850814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
